Verdiva Bio Funding: $411M Raised, Series A (2025)
Verdiva Bio is a Biotech company based in London, Country (or null). It has raised $411M in total funding. Latest round: Series A.
Verdiva Bio funding overview
Verdiva Bio is a Biotech company based in London, Country (or null). Verdiva Bio has raised $411M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Verdiva Bio runs through 2025; nothing later has been disclosed. Investors on record include Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Verdiva Bio at a glance
Total raised
$411M
Latest round
Series A
Latest round date
January 2025
Industry
Biotech
Headquarters
London, Country (or null)
Notable investors
Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, LYFE Capital
Frequently asked about Verdiva Bio funding
How much has Verdiva Bio raised?
Verdiva Bio has raised $411M in total disclosed funding across the rounds on record.
Who has invested in Verdiva Bio?
Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures are named among the investors backing Verdiva Bio.
What was the latest Verdiva Bio funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Verdiva Bio based?
Verdiva Bio is based in London, Country (or null).
What sector does Verdiva Bio operate in?
Verdiva Bio is tracked under Biotech from London, Country (or null), with $411M in disclosed funding.
When did Verdiva Bio last raise?
The last disclosed Verdiva Bio round closed in January 2025 at Series A.
Every Verdiva Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in London at a similar stage.
